Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2007, p. 2305-2308, Vol. 45, No. 7
0095-1137/07/$08.00+0 doi:10.1128/JCM.00102-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Microbiology and Infectious Diseases, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Received 15 January 2007/ Returned for modification 2 March 2007/ Accepted 4 May 2007
|
|
|---|
|
|
|---|
Positive controls were H. influenzae strains ATCC 9006 (type a), ATCC 9795 (type b), ATCC 9007 (type c), ATCC 9332 (type d), ATCC 8142 (type e), and ATCC 9833 (type f). The specificity of the real-time PCR assay for H. influenzae was tested with Streptococcus pneumoniae (ATCC 33400), Streptococcus oralis (ATCC 10557), Staphylococcus aureus (ATCC 65389), Staphylococcus epidermidis (ATCC 12722), Staphylococcus haemolyticus (ATCC 29970), Escherichia coli (ATCC 35039), Enterococcus faecalis (ATCC 29212), Haemophilus parainfluenzae, Haemophilus haemolyticus, Neisseria meningitidis, Neisseria gonorrhoeae, Moraxella catarrhalis, and Moraxella lacunata. Clinical strains isolated from blood, bronchoalveolar lavage (BAL) fluid, and sputa from patients aged less than 1 day to 84 years old were sent to the reference laboratory (Institut Jules Bordet) by Belgian microbiologists during 2004 and 2005 (n = 131). Capsular serotyping was performed by slide agglutination (with antisera against capsular antigen [Difco Haemophilus influenzae antisera]). A strong and rapid reaction with only one antiserum was required to record a positive test without autoagglutination.
DNAs were extracted as previously described (14), using a QIAamp DNA blood kit (QIAGEN, Hilden, Germany). Primers and probes designed for the detection of H. influenzae capsular types a to f (Hia to Hif) were targeted within variable region II of the encapsulation cap locus (21). For the bexA gene, several sequence variations have been reported (10, 12, 18, 19). We used the MegAlign program of DNASTAR, version 5.07 (Madison, WI), to compare 18 published bexA sequences (National Center for Biotechnology Information [NCBI] GenBank sequence database), and we chose a primer-probe combination situated in the most conserved regions. Moreover, one primer and probe set derived from the sequence for the gene coding for outer membrane lipoprotein P2 (ompP2), present in both encapsulated and noncapsulated (NC) Haemophilus strains, was also designed as a control for real-time PCR to confirm the H. influenzae species. The oligonucleotide sequences, PCR product lengths, locations, and GenBank accession numbers for the corresponding target genes are displayed in Table 1. Prior to experimental testing, these sequences were assessed for specificity by comparing them to sequences of other prokaryotic and eukaryotic organisms, using standard nucleotide-nucleotide BLAST (NCBI) alignment software. None of the selected oligonucleotides had significant homology to any other sequences. All primers and probes included in this study were designed using Primer Express software, version 2.0 (Applied Biosystems, Foster City, CA), and were synthesized by Invitrogen (Merelbeke, Belgium) and Applied Biosystems, respectively.
|
View this table: [in a new window] |
TABLE 1. Primers and probes for capsule type-specific H. influenzae detection by real-time PCR
|
Strains were first tested for the presence or absence of the bexA gene, region II of the cap locus of Hib, and the ompP2 gene by a multiplex real-time PCR-based assay. The ompP2 gene was used as an internal control for DNA extraction and amplification. Non-b capsulated H. influenzae strains were then checked in four real-time PCR-based assays, including a duplex assay for detection of types a and f and three uniplex assays for detection of types c, d, and e. Optimization of the multiplex PCR conditions, mainly the annealing temperature, was carried out with 2°C decrements in the annealing temperature to allow optimal annealing for all primer/probe systems in the mixture, as previously described (7).
The principle of real-time PCR has been described extensively (9). PCR mixtures were set up in a total volume of 25 µl, including 12.5 µl TaqMan universal master mix (Applied Biosystems) and 1 µl template DNA. The multiplex real-time PCR assay, covering bexA-Hib-ompP2, was optimized with the following primer concentrations: 300 nM for bexA and 50 nM for Hib and ompP2. The concentrations of the other primers and probes are specified in Table 1. The real-time PCR assays were performed using an ABI Prism 7500 sequence detection system (Applied Biosystems). For multiplex amplification, the cycling parameters were 50°C for 2 min and 95°C for 10 min, followed by 40 cycles comprising a denaturation step of 95°C for 15 s and annealing and primer extension at 58°C for 1 min. For duplex PCR, covering Hia and Hif, the same conditions were used, except for an annealing temperature of 60°C. Lastly, for uniplex amplifications, annealing temperatures were 58°C (types c and d) and 56°C (type e). Finally, conventional gel-based PCR capsular typing was performed by the method described by Falla et al. (5).
The sensitivities and detection efficiencies of the real-time PCR assays were assessed by repeated testing of 10-fold serial logarithmic dilutions of reference bacterial strains, starting from cultures of 108 CFU/ml. This was achieved by plotting the number of cycles necessary in each of the real-time PCRs to produce a fluorescence signal exceeding a threshold limit against the log10 of the number of microorganisms. All dilution series of Hia to Hif yielded similar regression lines, as follows: the amplification efficiencies were 3.200, 3.107, 3.106, 3.117, 3.305, and 3.151, respectively; the reproducibility and consistency of the replicates in real-time PCRs were 0.983, 0.988, 0.980, 0.994, 0.987, and 0.989, respectively; and the theoretical limits of detection of the reactions were 42.306, 39.232, 43.742, 48.672, 47.485, and 47.769, respectively. The actual sensitivities of the PCRs, referred to as the lowest standard dilutions constantly producing real-time amplification signals in replicate reactions, were 101 CFU per PCR for types a, b, and c; 103 CFU per PCR for type e; and 104 CFU per PCR for types d and f. The intra- and interassay variabilities of the CT values obtained with replicates of the same DNA extracted from each dilution series or with replicates from DNAs extracted from different dilution series were <1 (data not shown). Each H. influenzae capsule type-specific primer/probe system correctly identified its corresponding target strain, without cross-reaction with purified DNAs from heterologous species (the bacteria mentioned above). The primer/probe system specific for the bexA gene amplified only encapsulated strains; NC H. influenzae strains and nontarget microorganisms were not detected.
One hundred thirty-one H. influenzae isolates were tested using the real-time PCR-based approach. All strains yielded at least the ompP2 signal. Of these isolates, 9.16% (12/131 samples) displayed the bexA signal and were subsequently identified by the real-time PCR assay as capsule type b, e, or f (Table 2), while 90.84% (119/131 samples) of isolates did not display the bexA signal. These results were compared to those established by the slide agglutination test and gel-based PCR. Overall, there were 117 NC isolates by both PCR methods and nontypeable (NT) isolates by the slide agglutination test. Among the eight Hib strains typed by real-time PCR, three blood isolates (from unvaccinated patients 1, 2, and 4) and one BAL isolate (from patient 3) were fully concordant with both other methods, three blood isolates were concordant with the gel-based PCR result but NT by the slide agglutination test (patients 9 to 11), and one BAL isolate was NT by both slide agglutination and gel-based PCR (patient 8) (Table 2). One each of Hie (patient 5) and Hif (patient 6) isolates was fully concordant with all methods, and one was concordant with the slide agglutination test but NC by gel-based PCR (Hie blood isolate from patient 7) or concordant with the gel-based PCR result but NT with the slide agglutination test (Hif BAL isolate from patient 12). Two NC isolates by both PCR methods, both isolated from blood, were typed with the slide agglutination test as Hia (from patient 13) and Hie (from patient 14). The overall agreement rate between all three methods was therefore 93.89% (123/131 isolates), and that between real-time PCR and serotyping was 94.7% (124/131 isolates). As indicated above and shown in Table 2, serotyping results and real-time PCR results did not agree for seven isolates, four of which were recognized as type b, one of which was type f, and two of which were NC by PCR.
|
View this table: [in a new window] |
TABLE 2. Comparative results of agglutination test, conventional PCR, and real-time PCR obtained with blood and BAL fluid specimens from 14 patients
|
The strategy of identification of H. influenzae presented here, using a capsular typing scheme targeting all H. influenzae serotypes, could be used as a novel nonculture method for typing of H. influenzae. Compared to gel-based PCR, the new assay has the following added benefits: it includes an internal control for extraction and amplification (ompP2), it can be adapted in a quantitative format if needed, and it has a shorter turnaround time (1.5 h) than that of conventional PCR (5 to 6 h). On the other hand, due to its relatively low diagnostic sensitivity, poor specificity, and subjective reading, the serological determination of capsular type by the slide agglutination test can no longer be recommended for the workup of samples requiring precise and unequivocal identification, such as H. influenzae strains infecting immunized children. In the future, the development of a method with only two multiplexed real-time PCRs covering all capsular types, with the ability to use uniform PCR conditions, would be useful for economizing reagents and accelerating the diagnostic analysis.
Published ahead of print on 16 May 2007. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»